Brain delivery of lipid nanoparticles with shuttle peptides

 

Сохранить в:
Библиографические подробности
Авторы: Martinez Martinez, Noelia, Carrera Rodríguez, Laura, Vargas Monge, Ronny, Hernández Munain, Cristina, Suñé Pou, Marc, Suñé, Carlos
Дата публикации:2026
Описание:Lipid nanoparticles (LNPs) have gained growing attention as advanced drug delivery systems capable of addressing major challenges in the development of innovative therapies. They have been widely investigated to overcome the challenges of development delivery strategies for the Central Nervous System (CNS). Their small size, biomimetic lipid composition, and modifiable surface properties make them promising candidates for targeting the Blood Brain Barrier (BBB), leading to improved therapeutic interventions. This chapter provides an integrative overview of the main classes of LNPs and their manufacturing methods, offering insights into their design, characterization, and optimization for brain delivery. We first discuss the key physicochemical parameters —particle size, polydispersity index, surface charge, shape, crystallinity, and encapsulation efficiency— and their impact on biodistribution, stability, and BBB penetration. Formulation and manufacturing strategies are examined, from conventional approaches to microfluidic mixing. Special attention is given to surface modification strategies, including ligand conjugation and the technological variables influencing receptor-specific transport that determine brain targeting. We place particular emphasis on brain-shuttle peptides, which constitute the most widely employed approach for functionalizing LNPs. Finally, we summarize representative preclinical studies, emerging clinical trials, and key translational challenges —such as neurotoxicity, batch-to-batch reproducibility, and regulatory hurdles—, but also highlight the proved potential of LNPs to achieve successful clinical translation in other therapeutic areas. These advances provide valuable insights and technical precedents that may benefit the development of LNP-based therapeutics for CNS disorders, supporting future strategies targeting neurological and psychiatric disorders as well as brain tumors.
Страна:Kérwá
Институт:Universidad de Costa Rica
Repositorio:Kérwá
Язык:Inglés
OAI Identifier:oai:kerwa.ucr.ac.cr:10669/109140
Online-ссылка:https://www.sciencedirect.com/science/chapter/bookseries/abs/pii/S1054358926000220?via%3Dihub
https://hdl.handle.net/10669/109140
https://doi.org/10.1016/bs.apha.2026.02.005
Ключевое слово:Blood brain barrier (BBB)
Central nervous system (CNS)
Brain targeting
Drug delivery
Nanomedicine
Surface functionalization
Ligand conjugation
Active targeting
Peptide decorated nanoparticles
Clinical challenges